The demographic features and outcome indicators of the Barbados HIV Pre-exposure Prophylaxis Program, 2018-2019
[ABSTRACT]. Objectives. To assess the demographics, risk profiles and outcome indicators of one of the few government-supported programs on pre-exposure prophylaxis (PrEP) in the English-speaking Caribbean. Methods. Chart review of all persons enrolled ...
Traditional, complementary, and integrative medicine evidence map: a methodology to an overflowing field of data and noise
[ABSTRACT]. Every day there is criticism about lack of evidence on traditional, complementary, and integrative medicine (TCIM). But is this narrative evidence-based? Are we really missing research about TCIM? Or are we just not looking correctly at the ...
SITUATION IN NUMBERS: Region of the Americas 59,757,984 cases; 1,450,197 deaths; 56 countries/areas/territories affected. | Global 140,529,212 cases; 3,009,255 deaths; 235 countries/areas/territories affected.
SITUATION IN NUMBERS: Region of the Americas 59,550,930 cases; 1,444,736 deaths; 56 countries/areas/territories affected. | Global 139,758,010 cases; 2,998,311 deaths; 235 countries/areas/territories affected.
Risk Management Plans and Periodic Safety Reports for COVID-19 Vaccines: Recommendations for Their Request, Preparation, Management, and Assessment
The continuous assessment of benefits and risks, as well as effective communication among stakeholders, is key for protecting and promoting public health, and for strengthening public trust in vaccines and the authorities that oversee the vaccination ...
SITUATION IN NUMBERS: Region of the Americas 59,294,109 cases; 1,438,618 deaths; 56 countries/areas/territories affected. | Global 138,688,383 cases; 2,978,935 deaths; 235 countries/areas/territories affected.
El suicidio es un problema grave de salud pública envuelto en estigma, mitos y tabúes. Con un promedio anual de 81.746 muertes por suicidio y una tasa de suicidio ajustada por la edad de 9,3 por 100.000 habitantes (y una tasa no ajustada por la edad ...
Considerations on Thrombotic Events Following Administration of the AstraZeneca COVID-19 Vaccine in Europe, 7 April 2021
The Pan American Health Organization (PAHO) has issued this communiqué in response to the information circulating about potential risks associated with use of the COVID-19 vaccine developed by AstraZeneca and Oxford University, considering the reports ...